Leishmania donovani: cellular control of ornithine decarboxylase in promastigotes
1School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Abstract:
Ornithine decarboxylase, a key enzyme in polyamine biosynthesis, is essential for normal cell growth and proliferation. Furthermore, the inhibition of this enzyme is a potential way of controlling such growth. In order to shed light on the role of ornithine decarboxylase in regulation of Leishmania growth we examined the activity of this enzyme during the life cycle of these organisms. Exponentially growing Leishmania promastigotes were resuspended at a density of 3 x 10(6) cells/ml. 2 x 10(7) cells were withdrawn 24 hr later at different time intervals for induction studies and ornithine decarboxylase activity was measured. Ornithine decarboxylase showed a growth related pattern in L. donovani promastigotes. Induction studies showed that ornithine decarboxylase activity rapidly increased in late log phase cells when resuspended in fresh medium. A biphasic induction curve was observed similar to that observed in mammalian cells. The first peak was observed at 6 hr and the second at 16 hr. Cycloheximide and Actinomycin D inhibited induction at 16 hr by 65-68%. Polyamines at a level not inhibitory to growth (10 microM) inhibited ornithine decarboxylase induction by 30-40% late in the induction period. Putrescine and spermidine both inhibited the first peak of induction. Putrescine suppressed ornithine decarboxylase activity by 39% at 16 hr whereas spermidine by only 29%. The half life of ornithine decarboxylase in promastigote forms grown in the presence of cycloheximide was >6 hr. These studies indicate that although the Leishmanial ornithine decarboxylase follows a similar induction pattern to that previously reported in the mammalian cells, it is less susceptible to exogenous polyamines and is comparatively stable. This lack of ornithine decarboxylase regulation and turnover may be exploitable in the development of various therapeutic agents to inhibit Leishmanial growth.
Insights
Ornithine decarboxylase (ODC) is crucial for Leishmania growth. Its induction pattern in Leishmania resembles mammalian cells but shows less regulation by polyamines, suggesting therapeutic potential for controlling parasite growth.
Area of Science:
- Biochemistry
- Parasitology
- Molecular Biology
Background:
- Ornithine decarboxylase (ODC) is a critical enzyme in polyamine biosynthesis, vital for cell growth and proliferation.
- Inhibiting ODC presents a potential strategy for controlling cell growth, including parasitic organisms like Leishmania.
- Understanding ODC's role in Leishmania is essential for developing targeted therapeutic interventions.
Purpose of the Study:
- To investigate the activity and regulation of ornithine decarboxylase (ODC) during the life cycle of Leishmania.
- To compare the induction patterns and regulatory mechanisms of Leishmania ODC with those in mammalian cells.
- To explore the potential of targeting Leishmania ODC for antiparasitic drug development.
Main Methods:
- Measurement of ornithine decarboxylase (ODC) activity in Leishmania promastigotes at different growth stages.
- Induction studies involving cell resuspension and assessment of ODC activity over time.
- Inhibition assays using cycloheximide, Actinomycin D, putrescine, and spermidine to analyze ODC regulation and stability.
Main Results:
- Leishmania donovani ornithine decarboxylase (ODC) activity exhibited a growth-related pattern, with rapid induction in late log phase cells.
- A biphasic induction curve for ODC was observed, with peaks at 6 and 16 hours, similar to mammalian cells.
- Leishmania ODC showed reduced susceptibility to exogenous polyamines and greater stability (half-life >6 hours) compared to mammalian ODC.
Conclusions:
- Leishmania ornithine decarboxylase (ODC) induction shares similarities with mammalian cells but exhibits distinct regulatory properties.
- The relative stability and reduced susceptibility to polyamine feedback inhibition of Leishmania ODC present a potential vulnerability.
- Targeting this unique regulation of Leishmania ODC could offer a novel therapeutic strategy against Leishmania infections.
More Related Videos
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents


